Open access · CC-BY
via OpenAlex
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
Line Jee Hartmann Rasmussen, Jens E. V. Petersen, Jesper Eugen‐Olsen
Frontiers in Immunology · 2021 · ▲ 258 citations
Abstract
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation that plays a major role in immunosenescence and in development and progression of many diseases. But currently, there are no recognized standard biomarkers to assess SCI levels alone, and SCI is typically measured by combining biomarkers of acute inflammation and infection, e.g., CRP, IL-6, and TNFα. In this review, we highlight 10 properties and characteristics that are shared by the blood protein soluble urokinase plasminogen activator receptor (suPAR) and SCI, supporting the argument that suPAR is a biomarker of SCI: (1) Expression and release of suPAR is upregulated by immune activation; (2) uPAR and suPAR exert pro-inflammatory functions; (3) suPAR is associated with the amount of circulating immune cells; (4) Blood suPAR levels correlate with the levels of established inflammatory biomarkers; (5) suPAR is minimally affected by acute changes and short-term influences, in contrast to many currently used markers of systemic inflammation; (6) Like SCI, suPAR is non-specifically associated with multiple diseases; (7) suPAR and SCI both predict morbidity and mortality; (8) suPAR and SCI share the same risk factors; (9) suPAR is associated with risk factors and outcomes of inflammation above and beyond other inflammatory biomarkers; (10) The suPAR level can be reduced by anti-inflammatory interventions and treatment of disease. Assessing SCI has the potential to inform risk for morbidity and mortality. Blood suPAR is a newer biomarker which may, in fact, be a biomarker of SCI since it is stably associated with inflammation and immune activation; shares the same risk factors as many age-related diseases; is both elevated by and predicts age-related diseases. There is strong evidence that suPAR is a prognostic marker of adverse events, morbidity, and mortality. It is associated with immune activity and prognosis across diverse conditions, including kidney disease, cardiovascular disease, cancer, diabetes, and inflammatory disorders. Thus, we think it likely represents a common underlying disease-process shared by many diseases; that is, SCI. We review the supporting literature and propose a research agenda that can help test the hypothesis that suPAR indexes SCI, with the potential of becoming the new gold standard for measuring SCI.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fimmu.2021.780641
- Canonical
- link ↗
- Fetched
- 2026-10-02 MST
Cite this
APA
Rasmussen, L.J.H., Petersen, J.E.V., & Eugen‐Olsen, J. (2021). Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation. <em>Frontiers in Immunology</em>. https://doi.org/10.3389/fimmu.2021.780641
Vancouver
Rasmussen LJH, Petersen JEV, Eugen‐Olsen J. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation. Frontiers in Immunology. 2021. doi:10.3389/fimmu.2021.780641.
BibTeX
@article{line2021Solubl,
title = {Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation},
author = {Line Jee Hartmann Rasmussen and Jens E. V. Petersen and Jesper Eugen‐Olsen},
journal = {Frontiers in Immunology},
year = {2021},
doi = {10.3389/fimmu.2021.780641},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Inflammation 2014
Open access · CC-BY
Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease
The Bioscientist 2026
Open access · CC-BY
Association of Oxidative Stress and Inflammatory Biomarkers with Chronic Periodontitis:
Tzu Chi Medical Journal 2020
Open access · CC-BY
Arterial stiffness
Journal of the American Heart Association 2024
Open access · CC-BY
Frailty and Cardiovascular Health
African Health Sciences 2019
Open access · CC-BY
Association of inflammatory biomarkers with lung cancer in North Indian population
Deposito Adademico Digital Universidad De Navarra (University of Navarra) 2019
Preprint